Genetic polymorphisms of GSTP1, XRCC1, XPC and ERCC1: prediction of clinical outcome of platinum-based chemotherapy in advanced non-small cell lung cancer patients of Bangladesh-Reference-Cited by-同舟云学术

Genetic polymorphisms of GSTP1, XRCC1, XPC and ERCC1: prediction of clinical outcome of platinum-based chemotherapy in advanced non-small cell lung cancer patients of Bangladesh

Published:2020-09 Issue:9 Volume:47 Page:7073-7082
ISSN:0301-4851
Container-title:Molecular Biology Reports
language:en
Short-container-title:Mol Biol Rep

Author:

Bushra Most. Umme,Rivu Sanzana Fareen,Sifat Ali Ehsan,Nahid Noor Ahmed,Ahmed Maizbha Uddin,Al-Mamun Mir Md. Abdullah,Apu Mohd Nazmul Hasan,Islam Md. Siddiqul,Islam Md. Reazul,Islam Mohammad Safiqul^ORCID,Hasnat Abul

Publisher

Springer Science and Business Media LLC

Subject

Genetics,Molecular Biology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s11033-020-05771-2.pdf

Reference46 articles.

1. WHO (2018) WHO Cancer Factsheet. https://www.who.int/news-room/fact-sheets/detail/cancer. Accessed 28 Sep 2019

2. Rossi A, Maio MD (2016) Platinum-based chemotherapy in advanced non-small-cell lung cancer: optimal number of treatment cycles. Expert Rev Anticancer Ther 16:653–660. https://doi.org/10.1586/14737140.2016.1170596

3. Bonanno L, Favaretto A, Rosell R (2014) Platinum drugs and DNA repair mechanisms in lung cancer. Anticancer Res 34:493–501

4. Kilari D, Guancial E, Kim ES (2016) Role of copper transporters in platinum resistance. World J Clin Oncol 7:106–113. https://doi.org/10.5306/wjco.v7.i1.106

5. Sun N, Sun X, Chen B et al (2009) MRP2 and GSTP1 polymorphisms and chemotherapy response in advanced non-small cell lung cancer. Cancer Chemother Pharmacol 65:437. https://doi.org/10.1007/s00280-009-1046-1

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genetic polymorphisms and platinum-induced hematological toxicity: a systematic review;Frontiers in Pharmacology;2024-08-21

2. Genetic polymorphisms as potential pharmacogenetic biomarkers for platinum-based chemotherapy in non-small cell lung cancer;Molecular Biology Reports;2024-01-13

3. Gene polymorphism and prediction of toxicity to platinum‐based chemotherapy in patients with gynecologic cancer;Clinical and Translational Science;2023-11-27

4. Association of polymorphic markers of the XRCC1, ERCC5, TP53, CDKN1A1 genes with the survival of patients after platinum-based chemotherapy for triple negative breast cancer;Tumors of female reproductive system;2023-05-01

5. A review of pharmacogenetic studies in the Bangladeshi population;Drug Metabolism and Personalized Therapy;2023-03-01